BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Bay

  Roche Gets in on Bay Area Allakos’ $100M Funding Round

  The round was led by NEA and included Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital, and a large institutional investor.

  December 13, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  Harpoon Medical’s 16-Employee Office Will Stay Intact After Edwards Lifescience’s $100M Acquisition

  Harpoon’s former CEO also hinted at possible growth at the office, including new hires for engineering and clinical team members.

  December 13, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  What You Need to Know About Immune-Onc Therapeutics

  Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California.

  December 13, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Tango Therapeutics

  Tango officially launched in 2017 and hit the ground running as a cancer drug target discovery and drug development company based on CRISPR technology.

  December 13, 2017

   · 

  5 min read

   · 

  Mark Terry
• Pharm Country

  Regeneron Collaboration Programs Highlighted During Sanofi Analyst Day

  In a separate release today the companies also shared positive topline results for PD-1 antibody cemiplimab in advanced CSCC.

  December 13, 2017

   · 

  8 min read
• Business

  Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020

  Eli Lilly today announced its 2018 financial guidance, including low-single-digit revenue growth driven by volume from recently launched pharmaceutical products.

  December 13, 2017

   · 

  10 min read
• BioForest

  PhaseRx Receives Decision From the Nasdaq Hearings Panel for Continued Listing of Shares

  PhaseRx today announced it received a decision from the Nasdaq Hearings Panel granting PhaseRx’s request for continued listing on The Nasdaq Capital Market until January 31, 2018.

  December 13, 2017

   · 

  5 min read
• Pharm Country

  The Medicines Company to Host Investor Day on January 23, 2018

  The Medicines Company announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City.

  December 13, 2017

   · 

  2 min read
• Business

  Arrakis Therapeutics Announces Exclusive License to RNA-targeted Small Molecule Technology From the University of Pennsylvania

  The license allows utilization of technology related to families of compounds that selectively bind specific nucleic acid structures, called three-way junctions.

  December 13, 2017

   · 

  3 min read
• Pharm Country

  Janssen and Leading Advocacy Organizations Introduce Cancer.com, a Customizable Online Destination for People Impacted by Cancer

  The Janssen Pharmaceutical Companies of Johnson & Johnson are proud to announce the launch of Cancer.com, an online destination providing those impacted by cancer with useful information and tools at the right time.

  December 13, 2017

   · 

  5 min read